Skip to content

Cyberlith IX Implantable Pulse Generator

by Intermedics, Inc. 510(k)

Active United States

510(k) K801337

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK801337 Date23 Sep 1981ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Cyberlith IX Implantable Pulse Generator is a Class III implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients requiring temporary or permanent pacing support due to bradycardia or other conduction disorders.

This device is implanted subcutaneously and is intended for single-use within the body. It is regulated under FDA 510(k) clearance (K801337) and falls under the classification of an implantable pacemaker pulse-generator (DXY). The device is supplied sterile and requires surgical implantation by a qualified healthcare professional in a controlled clinical setting.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Cyberlith IX Implantable Pulse Generator used for in clinical practice?

    The Cyberlith IX Implantable Pulse Generator is designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients who require temporary or permanent pacing support due to bradycardia (slow heart rate) or other conduction disorders, ensuring consistent and controlled heartbeats.

  • Is the Cyberlith IX Implantable Pulse Generator intended for single-use or reusable applications?

    The Cyberlith IX Implantable Pulse Generator is explicitly designed for single-use within the body after surgical implantation. It is not intended for reuse or external applications, as it is meant to remain implanted subcutaneously as a permanent or temporary pacing solution.

  • How is the Cyberlith IX Implantable Pulse Generator supplied, and what are the handling requirements?

    The device is supplied sterile and requires surgical implantation by a qualified healthcare professional in a controlled clinical setting. Since it is implanted subcutaneously, it must be handled under sterile conditions to prevent infection and ensure proper functionality.

  • What regulatory pathway was followed for the Cyberlith IX Implantable Pulse Generator’s approval?

    The Cyberlith IX Implantable Pulse Generator was cleared through the FDA 510(k) process (K801337) under the classification of an Implantable Pacemaker Pulse-Generator (DXY). It was reviewed by the Cardiovascular (CV) Advisory Committee and determined to be substantially equivalent to prior devices, with a traditional clearance type.